En Es
Categories

DIASOURCE

Develops, manufactures, and markets clinical diagnostic products that focus on endocrinology and infectious diseases
Gold member
Products NewsSummary
Close

News of DIASOURCE

DIAsource Immunoassays Enters Agreement with ZenTech for RIA Products

31 Jul 2018
DIAsource Immunoassays Enters Agreement with ZenTech for RIA Products
DIAsource Immunoassays, a BioVendor group company, has entered into a strategic agreement with ZenTech under which ZenTech will transfer its portfolio of radioimmunoassays (RIA) products to DIAsource, securing their continued production and sales.
Read More

DIAsource ImmunoAssays SA Acquires Viro-Immun Diagnostics

19 Sep 2017
DIAsource ImmunoAssays SA Acquires Viro-Immun Diagnostics
DIAsource ImmunoAssays SA, which develops, sells and distributes clinical diagnostics products, has acquired Viro-Immun Diagnostics GmbH, a developer and manufacturer of laboratory diagnostics for the medical diagnosis of infectious and autoimmune diseases.
Read More
Close

About DIASOURCE

Number of Employees: 100-499
Year of Establishment: 1996
Develops, manufactures, and markets clinical diagnostic products that focus on endocrinology and infectious diseases
FaceBook Twitter Google+ Linked in
INS-EASIA Test

INS-EASIA Test

Model: KAP1251
Request Information

Description:

The KAP1251 INS-EASIA is a solid phase Enzyme Amplified Sensitivity Immunoassay for the in vitro quantitative measurement of human Insulin (INS) in serum. It is performed on breakable microtiterplates and uses monoclonal antibodies (MAbs) directed against distinct epitopes of insulin.


Send A Message To This Supplier

* Required Information
* Email
To
DIASOURCE (INS-EASIA Test)
* Message

Copyright © 2000-2019 TradeMed.com. All rights reserved. | Terms And Conditions